Led by FTV Capital, with participation from NVIDIA and existing investors, funding will further solidify Kore.ai's leading position in explosive advanced AI market ORLANDO, Fla., Jan. 30, 2024 /PRNewswire/ -- Kore.ai, a leader in enterprise conversational and generative AI platform technology, today announced $150 million in funding. The strategic growth investment was led by FTV Capital, a sector-focused growth equity investor with a successful 25+ year track record investing across enterprise technology, ...

Enfusion, Inc. (NYSE:ENFN) Q3 2023 Results Conference Call November 7, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Michael Infante - Morgan Stanley Faith Brunner - William Blair Elyse Kanner - JPMorgan Parker Lane - Stifel Crispin Love - Piper Sandler Callie Valenti - Goldman Sachs Natalie Howe - Bank of America Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion's Third Quarte ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other juri ...

Enfusion, Inc. (NYSE:ENFN) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Iggy Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Kevin McVeigh - Credit Suisse Parker Lane - Stifel James Faucette - Morgan Stanley Callie Valenti - Goldman Sachs Dylan Becker - William Blair Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a rem ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdict ...

Financial Performance Highlights - Revenue grew 20% year-over-year to $41 million, reflecting resilient client demand for software and services [7][21] - Adjusted EBITDA was $5.7 million, representing a margin of 13.9%, up over 850 basis points from the same period last year [79] - Annual Recurring Revenue (ARR) increased 21% year-over-year to $167 million [7][80] - Adjusted gross profit increased by 19% year-over-year to $27.9 million, with an adjusted gross margin of 68.2% [22] Business Line Performance - In the EMEA region, revenue grew 37% year-over-year, driven by strong sales execution, particularly in the Middle East [10] - U.S. revenue grew 16% year-over-year, reflecting market dynamics and successful partnerships with large hedge funds [36] - APAC revenue increased by 20% year-over-year, with significant wins in the region, including a large long/short equity hedge fund in Singapore [40] Market Dynamics - The investment management space is facing sustained macroeconomic headwinds, but signs of stabilization are emerging [16] - The industry is undergoing digital transformation, moving from legacy systems to integrated solutions, which presents opportunities for growth [17] - There is a healthy pipeline for conversions and upmarket opportunities, driven by the need for cost optimization among fund managers [45] Company Strategy and Competitive Positioning - The company is focused on enhancing its competitive advantage through best-in-class software and services [4] - Strategic partnerships, such as with Qontigo, are aimed at broadening the partner ecosystem and enhancing client offerings [13][14] - The company is investing in its core platform to improve functionality and streamline client onboarding and support [19] Management Commentary on Future Outlook - Management remains optimistic about the second half of the year, expecting improved market dynamics as macro uncertainty decreases [16][52] - The company is reaffirming its full-year revenue guidance of $185 million to $190 million and adjusted EBITDA guidance of $32 million to $34 million [52] - Management acknowledges short-term volatility in net dollar retention but anticipates recovery as new clients are onboarded [49][106] Other Important Information - The company ended the quarter with approximately $55 million in cash and cash equivalents and no debt, providing flexibility for strategic initiatives [23] - The average size of customers has increased by approximately 10% compared to the same period last year, reflecting a strategy to move upmarket [81] Q&A Session Summary Question: What is the outlook for ARR growth for the rest of the year? - Management expects ARR to continue growing, with some short-term pressure on existing clients but acceleration anticipated as new clients are onboarded [100][101] Question: Are there any assumptions of an improving macro environment in the guidance? - The guidance reflects expectations of a slower first half but reaffirmation of anticipated improvements in the back half of the year [102][103] Question: How is the company addressing pricing dynamics in the current environment? - The company is not seeing general price compression and maintains a competitive edge through its comprehensive solutions [95][116] Question: Can you provide insights on client churn and its impact on NDR? - Voluntary churn remains low, with the majority of churn being involuntary due to market conditions; management is closely monitoring these trends [70][71] Question: What is the visibility on recent conversion wins and their impact on revenue? - Management sees visibility in hedge fund launches picking up, with monetization timelines varying based on the complexity of the launches [66][68]

¨·· ënfusion PROPRIETARY AND CONFIDENTIAL ©2023 ENFUSION. ALL RIGHTS RESERVED. ©2023 ENFUSION. ALL RIGHTS RESERVED. 2 Statements we make in this presentation may include statements which are not historical facts and are considered forwardlooking within the meaning of Section 27A of the Securities Act of 1933 (Securities Act) and Section 21E of the Securities Exchange Act of 1934 (Exchange Act), including expectations regarding future financial performance. These forward-looking statements are usually identi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdic ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-40949 ENFUSION, INC. (Exact name of registrant as specified in its charter) Delaware 87-1268462 (State of Other Jurisdiction ...

Enfusion, Inc. (NYSE:ENFN) Q4 2022 Results Conference Call March 7, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants James Faucette - Morgan Stanley Kevin McVeigh - Credit Suisse Dylan Becker - William Blair Koji Ikeda - Bank of America Matthew Kikkert - Stifel Operator Good morning, ladies and gentlemen and thank you for standing by. Welcome to Enfusion's Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] A ...